Mark A. Rettenmaier MD FACOG FACS
Education
College:
University of Iowa
BS 1970-1973
Medical School:
University of Iowa
MD 1973-1977
Internship and Residency:
University of California, Davis
Obstetrics and Gynecology 1977-1981
Fellowship:
University of California, Irvine
Gynecologic Oncology 1981-1984
Medical Licensure
California
A32692 1978
Certification
American Board of Obstetrics and Gynecology
Obstetrics and Gynecology 1985
American Board of Obstetrics and Gynecology
Gynecologic Oncology 1986
American Board of Obstetrics and Gynecology
Fellow 1987
American College of Surgeons
Fellow 1987
American Association of Gynecologic Laparoscopy
Surgeon Designee 2012
Fundamentals of Laparoscopic Surgery 2018
Professional Background
Southern California Gynecologic Oncology
CEO 2016 -
Department of Obstetrics and Gynecology
Keck School of Medicine
University of Southern California
Adjunct Clinical Professor 2004 - 2019
Department of Obstetrics and Gynecology
University of California, Los Angeles
Associate Clinical Professor 1990 – 2013
Department of Obstetrics and Gynecology
Harbor/UCLA Medical Center
Clinical Associate Professor 1989 – 1998
Gynecologic Oncology Associates
Founding Partner 1988 - 2016
Department of Obstetrics and Gynecology
University of Nevada
Clinical Associate Professor 1985 – 1989
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
University of California, Irvine
Assistant Professor 1984 – 1988
Department of Obstetrics and Gynecology
Division Gynecologic Oncology
University of California, Irvine
Clinical Instructor 1981 – 1984
Professional Societies
American College of Obstetrics and Gynecology
American College of Surgeons
Society of Gynecologic Oncologists
American Society of Clinical Oncology
American Association of Gynecologic Laparoscopists
Awards
American Cancer Society
Junior Faculty Clinical Fellow 1985-1986
American Cancer Society
Junior Faculty Clinical Fellow 1984-1985
Excellence in Teaching Award
University of California, Irvine
Department of Obstetrics and Gynecology 1984
American Cancer Society
Regular Clinical Fellow. 1983 - 1984
Excellence in Teaching
University of California, Los Angeles
David Geffen School of Medicine
Department of Obstetrics and Gynecology 2010
Certificate of Appreciation
La Amistad Free Clinic, Orange, CA 2010
CalOptima Circle of Life Award 2011
Publications
1. Rettenmaier MA, Hanson F: A comparison of intravaginal prostaglandin e2 and intra-amniotic f2-alpha in second trimester abortion. Surg Gynecol Obstet 156:585-588 1982
2. Stratton JA; Braly, PS, Rettenmaier MA, DiSaia PJ: Depressed natural killer cell activity in tumor bearing rats: Effect of immunotherapy and cytoreductive chemotherapy. Clin Immunol Immunopathol 28:170-176 1983
3. Stratton JA, Rettenmaier MA, Berman ML, DiSaia PJ: The response of gynecologic tumors to chemotherapy: Correlation of the chemosensitivity predicted by the subrenal capsule implant assay with the clinical response of the patients. Thirteenth International Congress of Chemotherapy (ed. KH Spitzy and K. Karrer) 11:123-126 1983
4. Rettenmaier MA, Ray DA, Stospkopf CG, DiSaia PJ, Berman ML: The use of gallium scanning and HCG determination to follow resorption of an abdominal placenta. Am J Obstet Gynecol 146:471-473 1983
5. Stratton JA, Rettenmaier MA, Braly PS, DiSaia PJ: Accurate prediction of tumor growth in vivo: The subrenal capsule implant site. J Bio Response Mod 2:272-279 1983
6. Stratton JA, Rettenmaier MA, DiSaia PJ: In vivo antineoplastic activity of various biologic response modifiers: Adenocarcinoma of the ovary and breast. J Clin Lab Immunol 11:181-18 1983
7. Berns MW, Rettenmaier MA, McCullough J, Wilie A, Berman M, DiSaia PJ, Weinstein G: Response of psoriasis to red laser light (630) following systemic injection of hematoporphyrin derivative. Lasers in Surg Med 4:73 1983
8. McCullough JL, Weinstein GD, Rettenmaier MA, Berns MW: Cutaneous photosensitization by topical hematoporphyrin derivative formulations: Potential clinical applications. Proc ICLEO International Meeting 1983
9. Rettenmaier MA, Berman ML, DiSaia PJ, Burns RG, Berns MW: Photoradiation therapy of gynecologic malignancies. Gynecol Oncol 17:200-206 1984
10. Rettenmaier MA, Berman ML, DiSaia PJ, Burns RG, Weinstein GD, McCullough JL, Berns MW: Gynecological uses of photoradiation therapy, porphyrin localization and treatment of tumors. Prog Clin Bio Res 170:767 1984
11. Rettenmaier MA, Haesslein HC: The relationship of maternal weight status to selected pregnancy events. Gynecol Obstet Invest 17:183-189 1984
12. Rettenmaier MA, Moore EA, Berman ML, Stratton JA, DiSaia PJ: A murine model of squamous intraepithelial neoplasia. J Clin Lab Imunol 14:151-154 1984
13. Rettenmaier MA, Crade M, Isterm PD, DiSaia PJ, Berman ML: Drainage of a mucometra under real-time ultrasound guidance. J Clin Ultrasound 12:423-424 1984
14. Stratton JA, Micha JP, Rettenmaier MA, Braly PS, DiSaia PJ: Chemosensitivity testing of non-solid tumors by the subrenal capsule implant assay. Gynecol Oncol 17:185-188 1984
15. Rettenmaier MA, Miller RD, Berman ML, DiSaia PJ: A pharmacokinetic study of moxalactam in patients undergoing gynecologic surgery. Am J Obstet Gynecol 150:882 1984
16. Stratton JA, Kucera PR, Micha JP, Rettenmaier MA, Braly PS, Berman ML, DiSaia PJ: The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: Three years experience. Gynecol Oncol 19:336 1984
17. Rettenmaier MA, Senyei AE, Widde KJ, Stratton JA, DiSaia PJ: In vivo alteration of res phagocytosis by albumin microspheres. J Clin Lab Immunol 17:99 1985
18. Weckstein L, Boucher AR, Rettenmaier MA: Accurate diagnosis of early ectopic pregnancy. Obstet Gynecol 65:393-397 1985
19. Rettenmaier MA, Braly PS, Roberts WS, Berman ML, DiSaia PJ: Treatment of cutaneous vulvar lesions with skinning vulvectomy. J Repro Med 30:478 1985
20. Briggs GG, Berman ML, Lange S, Riker J, Rettenmaier MA, DiSaia PJ: Morphine: Continuous intravenous infusion versus intramuscular injections for postoperative pain relief. Gynecol Oncol 22:288 1985
21. York AC, Rettenmaier MA: An unusual complication of delayed treatment of fetal demise. Am J Obstet Gynecol 150:10 1985
22. Rettenmaier MA, Micha JP, Kucera PR, Berman ML, DiSaia PJ: A simplified method of right atrial catheter insertion. Gynecol Oncol 21:207 1985
23. Micha JP, Kucera PR, Preve CV, Rettenmaier MA, Braly PS, Berman ML, DiSaia PJ: Action of 2-beta-d-ribofurano sylthiazole-4-carboxamide (tiazofuran) against untreated human ovarian cancers in the murine xenograft assay. Gynecol Oncol 21:351 1985
24. Rettenmaier MA, Micha JP, Braly PS, Silva PD, Berman ML, DiSaia PJ: A semipermanent right atrial catheter in gynecologic cancer patients. Obstet Gynecol 66:559 1985
25. Micha JP, Kucera PR, Sheets EE, Rettenmaier MA, DiSaia PJ: Prophylactic mezlocillin in patients undergoing radical hysterectomy. Proceedings of the 11th World Congress of Gynecology and Obstetrics. Berlin, FRG 1985
26. Rettenmaier MA, DiSaia PJ: Early invasive vulvar cancer. 11th World Congress of Gynecology and Obstetrics. Berlin, FRG, 1985. Published in Archives of Gynecology (suppl) 1985
27. Rettenmaier MA, Stratton JS, DiSaia PJ: Murine xenograft chemosensitivity assay. 11th World Congress of Gynecology and Obstetrics. Berlin , FRG, 1985. Published in Archives of Gynecology (suppl) 1985
28. Stratton JA, Kucera PR, Rettenmaier MA, Micha JP, Braly PS, Berman ML, DiSaia PJ: Accurate laboratory predictions of the clinical response of advanced ovarian cancer patients to treatment with cyclophosphamide, doxorubicin and cisplatin. Gynecol Oncol 26:302 1986
29. Rettenmaier MA, Berman ML, DiSaia PJ: Treatment of advanced ovarian cancer with polyinosinic-polycytidylic acid (poly ICLC) Gynecol Oncol 24(3):359 1986
30. Rettenmaier MA, Stratton JA, Berman ML, Senyei A, Widder K, White DB, DiSaia PJ: Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labelled with doxorubicin or protein A. Gynecol Oncol 27(1):34-43 1987
31. Rettenmaier MA, Berman ML, DiSaia PJ: Skinning vulvectomy for the treatment of multifocal vulvar intraepithelial neoplasia: A re-appraisal. Obstet Gynecol 69(2):247 1987
32. Stratton JA, Rettenmaier MA, Kucera PR, Berman ML, DiSaia PJ: Concordance of combination and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA). Gynecol Oncol 30:416-421 1988
33. Homesley, HD; Blessing JA, Rettenmaier MA, Capizzi RL, Major FJ, Twiggs LF: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 72:413-418 1988
34. Rettenmaier MA, Moran MF, Ramsinghani NF, Colman M, Syed NA, Puthawala A, Jansen FW, DiSaia PJ: Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intra-arterial infusion of cisplatin. Cancer 61:1301-1303 1988
35. Stratton JA, Rettenmaier MA, Phillips HV, Herabutya S, DiSaia PJ: Relationship of serum CA-125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies. Obstet Gynecol 71(1):20-26 1988
36. Mannel RS, Stratton JA, Rettenmaier MA, Liao SY, DiSaia PJ: Use of a murine assay for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer. Gynecol Oncol 31:50-55 1988
37. Slayton RE, Blessing JA, Rettenmaier MA, Ball H: A phase II trial of diaziquone (AZQ) in the treatment of patients with recurrent nonsquamous cell carcinoma of the cervix. (A Gynecologic Oncology Group Study) Inv New Drugs 7(4): Nov 1989
38. Rettenmaier MA, Casanova D, Micha JP, Moran M, Ramsanghani N, Syed N, Puthawala A, DiSaia PJ: Radical hysterectomy and tailored postoperative radiation therapy for bulky stage 1B cervical cancer. Cancer 63:2220-2223 1989
39. Mannel RS, Stratton JA, Moran G, Rettenmaier MA, Liao S, DiSaia PJ: Intraperitoneal cisplatin: Comparison of antitumor activity and toxicity as a function of saline concentration in the solvent. Gynecol Oncol 34(1):50-53 1989
40. Stratton JA, Mannel RS, Rettenmaier MA, Berman ML, DiSaia PJ: Treatment of advanced and recurrent endometrial carcinoma: Correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay. Gynecol Oncol 32:55-59 1989
41. Chien RTY, Rettenmaier MA, Micha JP, DiSaia PJ: Ovarian epithelial tumors of low malignant potential. Surg Gynecol Obstet 169:143-146 1989
42. Kucera PR, Berman ML, Sheets EE, Micha JP, Rettenmaier MA, Treadwell P, DiSaia PJ: Whole abdominal radiotherapy for patients with minimal residual epithelial ovarian cancer. Gynecol Oncol 361(3):338-342 1990
43. Homesley HD, Blessing JA, Schlaerth J, Rettenmaier MA, Major F: Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. (A Gynecologic Oncology Group Study). Gynecol Oncol 39:305-308 1990
44. Peavy GM, Rettenmaier MA, Berns MW: Carbon dioxide laser ablation and doxorubicin treatment of vaginal fibrosacroma in a Am Veterinary Med Assoc 201(1):109-110 1992
45. Micha JP, Rettenmaier MA, Dillman R, Fraser P, Birk C, Brown, JV: Single Dose Dexamethasone Taxol Premedication. Gynecol Oncol 69:122-124 1998
46. Micha JP, Rettenmaier MA, Francis L, Willenberg R, Brown JV: “Medically Necessary” Panniculectomy to Facilitate Radical Pelvic Surgery in Morbidly Obese Patients. Gynecol Oncol 69:237-242 1998
47. Brown JV, Rettenmaier MA, Dillman R, Birk C, Culkin K, Micha JP: Three hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer. Gynecol Oncol 68:166-168 1998
48. Rettenmaier MA: Vulvar Intraepithelial Neoplasia III: Occult cancer and the impact of margin status on recurrence – Letter to the Editor. Obstet Gynecol 93(4) 1999
49. Brown JV, Peters WA, Rettenmaier MA, Karlan BY, Dillman RO, Smith MR, Drscher CW, Micha JP: A Phase I Trial of a 3-Day topotecan Q 21 Days for Recurrent epithelial Cancers of the Ovary, Fallopian Tube, and Peritoneum. Gynecol Oncol 79:495-498 2000
50. Brown JV, Peters WA, Rettenmaier MA, Graham CL, Smith MR, Drescher CW, Micha JP: Three Consecutive Day Topotecan is an Active Regimen for Recurrent Epithelial Ovarian Cancer. Gynecol Oncol 88 136-140 2003
51. Rettenmaier MA, Brown J, Micha M: Modified vestibulectomy is inadequate treatment for secondary vulvar vestibulitis. J Gynecol Surg 19(1):13-18 2003
52. Micha JP, Goldstein BH, Hunter JV, Rettenmaier MA, Brown JV: Long-term survival in an ovarian cancer patient with brain metastases. Gynecol Oncol 92:978-980 2004
53. Rettenmaier MA, Micha JP, Brown JV, Goldstein B: Impact of Gynecologic Oncologists on Referral Patterns and Care of Patients with Uterine Malignancies at a Community Hospital. J Gynecol Surg 20(2):57-63 2004
54. Micha JP, Goldstein BH, Rettenmaier MA, Mattison JA, Graham C, Birk CL, Brown JV: Pilot Study of Outpatient Paclitaxel, Carboplatin and Gemcitabine for Advanced Stage Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer. Gynecol Oncol 94:719-724 2004
55. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV: Cecal transposition following total pelvic exenteration. Gynecol Oncol 94:589-92 2004
56. Brown JV, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP: Laser ablation of surgical margins following excisional partial vulvectomy for vulvar intraepithelial neoplasia may decrease recurrences. J Reprod Med 50(5):345 2005
57. Micha JP, Goldstein BH, Robinson PA, Rettenmaier MA, Brown J: Abdominal/Pelvic Coccidioidomycosis. Gynecol Oncol 96(1):256-258 2005
58. Micha JP, Goldstein BH, Mattison JA, Bader KM, Graham C, Rettenmaier MA, Brown JV, Markman M: Experience with single agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel and gemcitabine in advanced ovarian cancer. Gynecol Oncol 96(1):132-135 2005
59. Brown JV, Goldstein BH, Duma CM, Rettenmaier MA, Micha JP: Gamma-Knife radiosurgery for the treatment of ovarian cancer metastatic to the brain. Gynecol Oncol 97:858-6 2005
60. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV, Markman M: Surgery alone or surgery with a combination of radiation or chemo-radiation for management of patients with bulky stage 1b2 cervical carcinoma. Int J Gynecol Cancer 16:1-5 2005
61. Rettenmaier MA, Goldstein BH, Stallman JM, Brown JV, Micha JP: Greatly elevated serum ca-125 level in a patient with a ruptured endometrioma. J Gynecol Surg 21: 109-112 2005
62. Brown JV, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP: Laser Ablation of Surgical Margins After Excisional Partial Vulvectomy for VIN. Obstet Gynecol Surv 60:584-5 2005
63. Rettenmaier MA, Goldstein BH, Stallman JM, Brown JV, Micha JP: Lymphoepithelial carcinoma of the cervix: Review and treatment course. J Gynecol Surg 21:(4)185-188 2005
64. Rettenmaier MA, Goldstein BH, Epstein HD, Brown JV, Micha JP: Serous psammocarcinoma of the ovary: An unusual finding. Gynecol Oncol 99:(2)510-511 2005
65. Micha JP, Goldstein BH, Birk CL, Rettenmaier MA, Brown JV: Abraxane in the treatment of ovarian cancer: The abscence of hypersensitivity reactions. Gynecol Oncol 100:437-438 2006
66. Micha JP, Goldstein BH, Bock BV, Rettenmaier MA, Brown JV. Spontaneous bacterial peritonitis: Int J Gynecol Surg 16:908-911 2006
67. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV: A rare case of coccygeal endometriosis: Obstet Gynecol 107(2):1 2006
68. Fiorentino RP, Zepeda MA, Goldstein BH, John CR, Rettenmaier MA: Pilot Study Assessing Robotic Laparoscopic Hysterectomy and Patient Outcomes. JMIG 13:60-63 2006
69. Rettenmaier MA, Goldstein BH, Brown JV, Micha JP: Serous Endometrial Intraepithelial Carcinoma: Diagnosis and Clinical Management. J Gynecol Surg 22:73-75 2006
70. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV: Neovagina reconstruction utilizing bladder and urethra following radical radiation therapy. J Gynecol Surg 22:73-75 2006
71. Micha JP, Goldstein BH, Rettenmaier MA, Caillouette JT, Fee MJ, Brown JV: Pelvic radiation necrosis and osteomyelitis following chemoradiation fo advanced stage vulvar and cervical carcinoma. Gynecol Oncol 101: 349-352 2006
72. Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV: A response to Batt: A Rare Case of Precoccygeal Endometriosis. Obstet Gynecol 108:213-214 2006
73. Micha JP, Goldstein BH, Epstein HD, Rettenmaier MA, Brown JV: Ovarian cancer metastatic to the breast. Gynecol Oncol 102:386-390 2006
74.Rettenmaier MA, Goldstein BH, Micha JP, Brown JV. Vaginal reconstruction following supralevator total pelvic exenteration. Gynecol Oncol 102:397-399 2006
73. Rettenmaier MA, Goldstein BH, Brown JV, Micha JP: Recurrent gestational trophoblastic disease following persistently normal hCG titers: A rare occurence. Am J Clin Oncol 30(1) 1 2007
74. Micha JP, Goldstein BH, Rettenmaier MA, Oglevie S, Lindsay SF, Haskell R, Brown JV: Subclavian artery puncture repair with Angio-Seal deployment. Gynecol Oncol 104: 761-3 2007
75. Micha JP, Goldstein BH, Zusman D, Rettenmaier MA, Epstein HD, Brown JV: Malignant pericardial effusion secondary to ovarian adenocarcinoma. J Reprod Med 52:971-973 2007
76. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV. A Precarious Case of Multiple Enlarged Arteriovenous Malformations in the Uterus. J Gynecol Surg 23: 220-4 2007
77.Micha JP, Goldstein BH, Graham C, Rettenmaier MA, Brown JV, Markman M: Improved survival with single-agent Taxol consolidation/maintenance therapy in advanced ovarian carcinoma. Oncol 71:49-53 2007
78. Micha JP, Goldstein BH, Brown JV, Birk C, Van Horn D, Rettenmaier MA: Tuberculosis mimicking cervical carcinoma. Euro J Gynecol Oncol 28(4):316 2007
79. Micha JP, Goldstein BH, Rettenmaier MA, Genesen M, Graham CL, Bader K,Lopez KL, Nickle M, Brown JV: A Phase II Study of Outpatient First Line Paclitaxel,Carboplatin and Bevacizumab for Advanced Stage Epithelial Ovarian, Peritoneal, andFallopian Tube Cancer. Intl J Gynecol Cancer 17:1-6 2007
80. Micha JP, Goldstein BH, Ellison D, Brown JV, Rettenmaier MA: Low-Grade Pelvic Masses with Spindle Cell and Fibroblastic Proliferation: Case Report: J Med Case Rep 1:16 2007
81. McClellan SN, Hamilton B, Rettenmaier MA, Goldstein BH, Lopez K, John CR: Individual Physician Experience with Laparoscopic Supracervical Hysterectomy in a Single Outpatient Setting. Surg Inn 14(2) 2007
82. Micha JP, Rettenmaier MA, Kistler M, Epstein HD, Lim J, Brown JV, Goldstein BH: Retroperitoneal Schwannoma Presenting as a Gynecologic Mass: A Rare Case Report. J Gynecol Surg 23:157-162 2007
83. Brown JV, Epstein HD, Kim R, Micha JP, Rettenmaier MA, Mattison JA, Goldstein BH: Rapid Manifestation of CNS Metastatic disease in a Cervical Carcinoma Patient: A Case Report. Oncology 73:273-276 2007
84. Micha JP, Goldstein BH, Rettenmaier MA, Tinnerman-Minailo E, Brown JV, McCllellan S, Bock BV: Recurrent Vulvar Lymphangitis Cured with Vulvectomy in a Cervical Carcinoma Patient: J Reprod Med 53:299 2008
85. Brown JV, Goldstein B, Lopez K, Rettenmaier MA, Graham C, Micha P: A phase II multi-center trial of weekly topotecan in patients with recurrent platinum sensitive epithelial cancers of the ovary, fallopian tube, and peritoneum. Int J Gynecol Cancer 18:249-254 2008
86. Micha JP, Goldstein BH, Clark M, Hu JC, Brown JV. Rettenmaier MA: Successful Management of Acute Renal Failure with Vaginal Pessary: A Case Report. Gynecol Surg 5:49-51 2008
87. Rettenmaier MA, Brown JV, Micha JP, Heineman FS, Goldstein BH: Marlex Mesh Mimicking an Adnexal Malignancy. Hernia 13:221-223 2009
88. Goldstein BH, Birk CL, Van Houten M, Veve R, Brown JV, Rettenmaier MA, Micha, JP: Ovarian cancer and late onset paraneoplastic cerebellar degeneration. Arch Gynecol Obstet 280:99-101 2009
89. Micha JP, Graham CL, Rettenmaier MA, Brown JV, Goldstein BH: Innovative Clinical Research: The Women’s Cancer Research Foundation Experience. Perspect Health Inf Manag 6:1-12 2009
90. Rettenmaier MA, Lopez K, Graham CL, Brown JV, John CR, Micha JP, Goldstein BH: RealHand High Dexterity Instruments for the Treatment of Stage 1 Uterine Malignancy. J Soc Laparoendoscopic Surg 13:27-30 2009
91. Hamilton B, McClellan SN, Rettenmaier MA, Goldstein BH: Laparoscopic supracervical hysterectomy for benign gynecologic conditions. J Soc Laparoendoscopic Surg 13:19-21 2009
92. Rettenmaier MA, Zekry N, Chang M, Palmer A, Brown JV, Micha JP, Goldstein BH: A Heavily Pigmented Vaginal Perivascular Epithelioid Neoplasm. J Obstet Gynaecol 29:676 – 677 2009
93. Rettenmaier MA, Lopez, K, Abaid LN, Brown JV, Micha JP, Goldstein BH: Borderline Ovarian Tumors and Extended Patient Follow-up: An Individual Institutions’s Experience. J Surg Oncol 101:18-21 2009
94. Rettenmaier MA, Abaid LN, Erwin MR, John CR, Micha JP, Brown JV, Goldstein BH: A Retrospective Review of the GelPort System in Single-Port Access Pelvic Surgery. J Min Invasive Gynecol 16:743-7 2009
95. Zeckry N, Rettenmaier MA, Abaid LN, John CR, Micha JP, Brown JP,Goldstein BH: Perivascular Epithelioid Cell Neoplasms: A Systematic Review of Prognostic Factors. J Minim Invasive Gynecol 16:527-32 2009
96. Rettenmaier MA, Abaid LN, Brown JV, Micha JP, Goldstein BH: Chemotherapy and patient co-morbidity in ventral site hernia development. J Gynecolo Oncol 20:246-50 2009
97. Brown JV, Tinnerman-Minailo EJ, Rettenmaier MA, Micha JP, Goldstein BH: The Minailo Knot: a time-saving and cost-saving technique. J Robotic Surg January 2010
98. Brown JV, Micha JP, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH: A Pilot Study Evaluating a Novel Regimen Comprised of Carboplatin, Paclitaxel, and Bevacizumab for Advanced Stage Ovarian Carcinoma. Int J Gynecol Cancer 20:1132-1136 2010
99. Abaid LN, Goldstein BH, Micha JP, Rettenmaier MA, Brown JV, Markman M: Improved Overall Survival with 12 Cycles of Single-Agent Paclitaxel Maintenance Therapy following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma. Oncology 78:389-393 2010
100. Rettenmaier MA, Epstein HD, Abaid LN, Bechtol KA, Goldstein BH: Leiomyosarcoma with Synchronous Clear Cell Carcinoma. Onkologie 33(12):695-697 2010
101. Abaid LN, Goldstein BH, Lopez KL, Micha JP, Brown JV, Rettenmaier MA, Markman M: The Prognostic Significance of Optimal Debulking in the Setting of a Complete Clinical Response for Advanced Ovarian Carcinoma Patients Receiving Maintenance Chemotherapy. Arch Gynecol Obstet 283:1127-1131 2011
102. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV, John CR, Markman M: The Clinical Utility of CA-125 for Maintenance Therapy in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Gynecol Cancer 19:239-241 2009
103. Brown III JV, Epstein HD, Mattison JN, Micha JP, Rettenmaier MA, Goldstein BH: Occult Fallopian Tube Cancer in a BRCA-1 Breast Cancer Patient: A Case Report. J Minim Invasive Gynecol 15;749-51 2008
104. Lawrence GC, Rettenmaier MA, Heinemann S, Chang M, Goldstein BH: A Precarious Pregnancy involving a Patient with a Large Placental Chorioangioma. Arch Obstet Gynecol 278:383-6 2008
105. Micha JP, Brown JV, Sheffer EC, Chan K, Rettenmaier MA, Goldstein BH: Sarcoidosis Imitating Metastatic Cervical Cancer. Arch Gynecol Obstet 277:441-3 2008
106. Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH: Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. Oncology. 81:79-83 2011
107. Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH: Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 17:569-74 2012
108. Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH: Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer. J Gynecol Oncol 23:22-27 2012
109. Rettenmaier MA, Goldstein BH: Response to Laparoscopic surgery for endometrial cancer: Why don’t all patients go home the day after surgery? J Min Invas Gynecol (Letter to Editor) 19:402 2012
110. Rettenmaier MA, Mendivil AA, Brown JV III, Abaid LN, Micha JP, Goldstein BH: Same Day Discharge in Clinical Stage 1 Endometrial Cancer Patients Treated with Total Laparoscopic Hysterectomy, Bilateral Salpingoophorectomy and Bilateral Pelvic Lymphadenectomy. Oncol 82:321-326 2012
111. Cupp JS, Illeck J, Rahbar N, Rettenmaier MA, Goldstein BH: A Rare Case of Primary Retroperitoneal Mucinous Adenocarcinoma. J Reprod Medicine 58: 85-88 2013
112. Mendivil AA, Micha JP, Brown JV 3rd, Rettenmaier MA, Abaid LN, Lopez KL, Goldstein BH: Increased incidence of severe gastrointestinal events with first-line Paclitaxel, Carboplatin, and Vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer. Int J Gynecol Cancer 23:533 2013
113. Cupp JS, Rettenmaier MA, Chang M, Goldstein BH: A very rare case of synchronous carcinomas of the endometrium and ovary with peritoneal keratin granulomatous involvement. Gynecol Oncol 5:1-3 2013
114. Micha JP, Brown JV, Rettenmaier MA, Abaid LN, Mendivil AA, Lopez KI, Goldstein BH: Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced stage ovarian cancer. Clin Oncol Feb (letter) 2013
115. Abaid LN, Micha JP, Rettenmaier MA, Brown JV, Mendivil AA, Lopez KL, Goldstein BH: A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Cancer Chemother Pharmacol 72:101-107 2013
116. Rettenmaier MA, Wong H, Stone MK, Bechtol KA, Goldstein BH: Vorinostat is a Potential Precipitant for Severe Gastrointestinal Toxicity. Am Surg 79:320-321 2013
117. Rettenmaier MA, Khan HJ, Epstein HD, Nguyen D, Abaid LN, Goldstein BH: Gestational Choriocarcinoma in the Fallopian Tube. J Obstet Gynaecol 912-914 2013
118. Brown III JV, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH: Robotic-Assisted Surgery for the Treatment of Pelvic Masses in Pregnant Patients: A Series of Four Cases and Literature Review. J Robot Surg 7:333–337 2013
119. Rettenmaier MA, Gray CM, Lopez KL, Bechtol KA, Goldstein BH. The retreatment of carboplatin via high-dose intraperitoneal chemotherapy in patients with a history of a hypersensitivity reaction. Am J Obstet Gynecol 210: e1-2 2014
120. Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Micha JP, Goldstein BH: The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study. Int J Surg 12:783-787 2014
121. Brown JV, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH: The Safety and Feasibility of Robotic Lymph Node Staging in Early-Stage Ovarian Cancer. Int J Gynecol Cancer 24(8) 2014
122. Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV, Wilcox AM, Goldstein BH: Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Hyperthermia 31:8-14 2015
123. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH: A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients. J Laparos Surg 19:15 2015
124. Rettenmaier MA, Mendivil AA, Gray CM, Chapman AP, Stone MK, Tinnerman EJ, Goldstein BH: Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia 24:1-7 2015
125. Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH:
The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma. Arch Gynecol Obstet 291:1381-6 2015
126. Rettenmaier MA, Abaid LN, Brown JV 3rd, Mendivil AA, Lopez KL, Goldstein BH: Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. Int J Surg 19:27-30. 2015
127. Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH: A randomized, controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancer. Int J Gynecol Cancer. 26:389-393 2016
128. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, Goldstein BH: Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience. Surg Oncol 25: 66-71 2016
129. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Mori KM, Lopez KL, Goldstein BH: Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: A 3 year experience. Cancer Chemother Pharmacol 80:405-410 2016
130. Rettenmaier MA, Goldstein BH: Reply to: #00279 Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study. (Letter to Editor) Int J Surg 41:209 2017
131. Rettenmaier MA, Micha JP, Lopez KL, Wilcox AM, Goldstein BH: A prospective, observational trial assessing the efficacy of abdominal compression in reducing Laparoscopy induced shoulder pain. Surg Innov 24(6): 552-556 2017
132. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV, Mori KM, Goldstein BH: The impact of total parenteral nutrition on postoperative recovery in patients treated for advanced stage ovarian cancer. Arch Gynecol Obstet 295:439-444 2017
133. Rettenmaier MA, Micha JP, Bogart R, Goldstein BH: A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol 2020; 244:101-105.
134. Rettenmaier MA. Confounding variables in survival analysis: Response to letter to the editor. Eur J Obstet Gynecol Reprod Biol 247: 257-271. http://dx.doi.org/10.1016/j.ejogrb.2020.02.038.
135. Rettenmaier MA, Micha JP, Bohart R, Epstein HD, King MM, Goldstein BH: Incidence and risk factors of ovarian cancer and breast cancer following prophylactic surgery: A retrospective cohort study. J Gynecol Surg 36:189 2020
136. Micha JP, Epstein HD, Rosen MC, Bohart R, Rettenmaier MA, Goldstein BH: Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage IVA cervical carcinoma. Eur J Gynaecol Oncol 2020; 41:797-801
137. Micha JP, Rettenmaier MA, Bohart R, Goldstein BH: Talc powder and ovarian cancer: What is the evidence? Arch Gynecol Obstet https://doi.org/10.1007/s00404-022-06539-8
138. Micha JP, Rettenmaier MA, Bohart R, Goldstein BH: Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient. Anti-Cancer Drugs 33:513-515 2022
139. Micha JP, Rettenmaier MA, Bohart R, Goldstein BH: A Phase 2, open-label, non-randomized, prospective study assessing Paclitaxel, Carboplatin and Metformin in the treatment of advanced stage ovarian carcinoma. J Gynecol Onc (Accepted for publication, 11/2022)
140. Micha JP, Rettenmaier MA, Bohart R, Goldstein BH: Hormone therapy and the risk for breast cancer: The controversy remains. J Menopause Med 28:1-5 2022
141. Micha JP, Rettenmaier MA, Bohart R, Goldstein BH: Robotic-assisted surgery for the treatment of breast and cervical cancers. J Soc Laparoscopic Robotic Surg 26(2):Apr-Jun 2022
142. Rettenmaier MA, Micha JP, Bohart R, Goldstein BH: Massive retroperitoneal leiomyoma of the cervical stump presenting as an ovarian fibroma in a postmenoion)pausal patient. J Gynecol Surg Doi: https://doi.org10.1089/Gyn.2022.0115 2022
143. Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH: Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration? J Obstet Gynecol Apr 2023
144. Rettenmaier MA, Micha JP, Bohart RD, Goldstein BH: Reply to a letter to the editor: A response to Tran and Egilman. Arch Gynecol Obstet https://doi.org/10.1007/s00404-023-07013-9 3/2023)
145. Micha JP, Rettenmiaer MA, Bohart RD, Goldstein BH: Does Aspirin Use Reduce the Risk for Ovarian Cancer? Exp Rev Anticancer Ther 2023 (accepted for publication)
146. Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH: Current Analysis of the Survival Implications for Minimally Invasive Surery in the Treatment of Early-Stage Cervix Cancer. J Robot Surg 2024 (accepted for publication)
147. Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. CDK4/6 Inhibitors in the Treatment of Advanced or Metastatic Breast Cancer. J Oncology Pharm Pract 2024 (accepted for publication)
148. Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH: Statin Use and Ovarian Cancer Outcomes. (submitted for publication , April 2024)
Non-Peer Reviewed Publications
1. Rettenmaier MA: Diagnosis of ectopic pregnancy. Ob/Gyn Clini-Pearls 5:3-4 1984
2. Rettenmaier MA, Kakkis JA: Endometrial cancer. Ob/Gyn Clini-Pearls 6:5 1984
3. Rettenmaier MA, Kucera PR: Colorectal cancer screening: Role of the Gynecologist. Contemp Obstet Gynecol Aug, 1985
4. Rettenmaier MA: The murine subrenal capsule assay. Gynecologic Oncology Newsletter. University of California Irvine, Medical Center 6(2) 1985
5. Rettenmaier MA: Early invasive vulvar cancer. Gynecologic Oncology Newsletter. University of California Irvine, Medical Center 6(2) 1985
6. Rettenmaier MA, DiSaia PJ: Radical hysterectomy for carcinoma of the cervix. Ob/Gyn Illustrated. April, 1986
7. Rettenmaier MA: Early invasive vulvar cancer. Cancer Surveillance Project of Orange County (CSPOC) Scanner 2:4 1986
8. Rettenmaier MA: The murine subrenal capsule assay. Cancer Surveillance Project of Orange County (CSPOC) Scanner 2:8 1986
9. Rettenmaier MA, DiSaia PJ: Understanding current vaginectomy techniques. Contemp Ob/Gyn 30/(2):109-117 1987
Books
1. Rettenmaier MA, DiSaia PJ: Vulvar disease and vulvectomy (in) Current Therapy in Surgical Gynecology
(ed. C. Garcia; JJ Mikuto; NG Rosenblum) BC Decker, Inc. Philadelphia 1987
2. Berns MW, Rettenmaier MA, McCullough J, Coffey J, Wile A, Berman ML, DiSaia PJ, Weinstein G: Response of psoriasis to red laser light (630nm) following systemic injection of hematoporphyrin derative.(in) Hematoporphyrin Derivative Photoradiation Therapy of Cancer. pgs. 73-77 Alan R Liss, Inc. New York , 1985 (also published as) Lasers in Surgery and Medicine 4:73-77 1984
3. Rettenmaier MA, Berman ML, DiSaia PJ, Burns RG, Weinstein GD, McCullough JL, Berns MW: Gynecologic uses of photoradiation therapy. (in) Porphyrin Localization and Treatment of Tumors. (ed. DR Doiron, CJ Gomer) Alan R Liss, Inc. New York 1984
4: Rettenmaier MA, Stratton JA, DiSaia PJ: The Murine Subrenal Capsule Assay (in) Gynecology and Obstetrics (ed. H Ludwig, K Thomsen) Springer-Verlag. Berlin, FRG 1986
5. Rettenmaier MA, DiSaia PJ: Early Invasive Vulvar Cancer (in) Gynecology and Obstetrics. (ed. H Ludwig, K Thomsen) Springer-Verlag. Berlin, FRG 1986
6. Rettenmaier MA, DiSaia PJ: Vaginectomy (in) Gynecologic Surgery pg. 151 (ed. Luis E. Sanz)Medical Economics Books. New Jersey 1988
7. Rettenmaier MA: Gynecologic Oncology Update (in) Prolog Gynecology (2nd edition)(ed. Harrison C Visscher) The American College of Obstetricians and Gynecologists 1988
Presentations
1. Trelford JD, Rettenmaier MA, Deer DA: Carcinoma of the vulva: A review. Western Association of Gynecologic Oncologists Annual Meeting. Napa, California 1981
2. Rettenmaier MA, Haesslein HC: The relationship of maternal weight status to selected pregnancy risk factors. District Eight and Nine, American College of Obstetrics and Gynecology Annual Meeting. Vancouver, British Columbia 1981
3. Rettenmaier MA, Stratton J, DiSaia PJ: The effect of magnetically responsive albumin microspheres on phagocytic function. Thirteenth International Cancer Congress. Seattle, Washington 1982
4. Stratton JA, Braly PS, Rettenmaier MA, DiSaia PJ: Predicting chemotherapeutic sensitivity for human ovarian tumors: A comparison of three assays. Thirteenth International Cancer Congress. Seattle, Washington 1982
5. Rettenmaier MA, Haesslein HC, Niswander KR: The relationship of maternal weight status to selected pregnancy events. EJ Quilligan Symposium. San Diego, California 1982
6. Rettenmaier MA: Antitumor activity of a polynucleotide interferon inducer in human ovarian cancer. Western Association of Gynecologic Oncologists Annual Meeting, Santa Fe, New Mexico. 1982
7. Rettenmaier MA, Stratton JA, Berman ML, DiSaia PJ: Therapy of Gynecologic Tumors. Gynecologic Oncology Group Annual Clinical Meeting Colorado Springs, Colorado 1983.
8. Stratton JA, Micha JP, Braly PS, Rettenmaier MA, DiSaia PJ: Correlation between chemotherapeutic sensitivity measured by the subrenal capsule tumor implant assay and the clinical response of patients with gynecologic tumors. Thirteenth International Congress of Chemotherapy. Houston, Texas 1983
9. Micha JP, Stratton JA, Senyei AE, Braly PS, Rettenmaier MA, Berman ML, DiSaia PJ: The effect of tumor burden on tumor growth and response to chemotherapy in immunocompetent mice. Society of Gynecologic Oncologist Annual Meeting. Scottsdale, Arizona 1983
10. Boucher AR, Weckstein LN, Rettenmaier MA: Accurate diagnosis of ectopic pregnancy. District Eight and Nine, American College of Obstetrics and Gynecology Annual Meeting. Monterey, California 1983
11. Rettenmaier MA, Miller RD, Berman ML, Stratton JS, DiSaia PJ: Penetration of moxalactam in patients undergoing gynecologic cancer surgery. Western Association of Gynecologic Oncologists Annual Meeting. Colorado Springs, Colorado 1983
12. Rettenmaier MA, Berman ML, DiSaia PJ, Burns RG, Berns M: Gynecologic uses of photoradiation therapy. Clayton Foundation Symposium on Porphyrin Localization and Treatment of Tumors. Santa Barbara, California 1983
13. Stratton J, Micha JP, Braly PS, Rettenmaier MA, Berman ML, DiSaia PJ: The response of gynecologic tumors to chemotherapy: Correlation of the chemosensitivity predicted by the subrenal capsule implant assay with the clinical responses of the patients. Thirteenth International Congress of Chemotherapy. Houston, Texas 1983
14. Rettenmaier MA, Braly PS, Roberts WS, Berman ML, DiSaia PJ: Treatment of cutaneous vulvar lesions with skinning vulvectomy. Western Association of Gynecologic Oncologists Annual Meeting. Colorado Springs, Colorado 1983
15. Micha JP, Rettenmaier MA, DiSaia PJ, Gupta S: Immunologic assessment of ovarian cancer patients treated with interferon. Western Association of Gynecologic Oncologists Annual Meeting. Colorado Springs, Colorado 1983
16. McCullough JL, Weinstein GD, Rettenmaier MA, Berns MW: Cutaneous photosensitization by topical hematoporphyrin derivative formulations: Potential clinical applications. ICLEO International Meeting. Los Angeles, California 1983
17. Micha JP, Berman ML, Romansky S, Rettenmaier MA, Flamm MS, Kucera PR, DiSaia PJ: Malignant ovarian germ cell tumors: A review of 17 cases. Society of Gynecologic Oncologists Annual Meeting. Miami, Florida 1984
18. Rettenmaier MA, Braly PS, Micha JP, Silva PD, Edwards GS, Berman ML, DiSaia PJ: The use of a permanent right atrial catheter in gynecologic cancer patients. Felix Rutledge Society Atlanta, Georgia 1984
19. Briggs GG, Berman ML, Lange S, Bohart R, Riker J, Braly PS, DiSaia PJ, Rettenmaier MA: Comparison of two regimens of postoperative pain control in gynecologic cancer patients. Western Association of Gynecologic Oncologists Annual Meeting. Sun River, Oregon 1984
20. Rettenmaier MA, Stratton JA, DiSaia PJ, Berman ML, Senyei A, Widder K: Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labelled with adriamycin or protein A. Society of Gynecologic Oncologists Annual Meeting. Miami, Florida 1985
21. Kucera PR, Sheets EE, Micha JP, Rettenmaier MA, Berman ML, DiSaia PJ: Whole abdominal radiotherapy for patients with minimal residual epithelial ovarian cancer. Western Association of Gynecologic Oncologists Annual Meeting. San Diego, California 1985
22. Micha JP, Kucera PR, Birkett JP, Rettenmaier MA, Chambers G, Sheets EE, Stoskopf CG, Berman ML, DiSaia PJ: Prophylactic mezlocillin in radical hysterectomy. Western Association of Gynecologic Oncologists Annual Meeting. San Diego, California 1985
23. Rettenmaier MA, Berman ML, Braly PS, Micha JP, Kucera PR, DiSaia PJ: Skinning vulvectomy for treatment of vulvar intraepithelial neoplasia. Western Association of Gynecologic Oncologists Annual Meeting. San Diego, California 1985
24. Micha JP, Kucera PR, Sheets EE, Rettenmaier MA, DiSaia PJ: Prophylactic mezlocillin in patients undergoing radical hysterectomy. 11th World Congress of Gynecology and Obstetrics. Berlin, FRG 1985
25. Stratton JA, Rettenmaier MA, Kucera PR, Berman ML, DiSaia PJ: Concordance of multiple and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA). American Association of Cancer Researchers Annual Meeting, Los Angeles, California 1986
26. McCullough JL, Berns MW, Rettenmaier MA: Photosensitizers in dermatology. American Society for Photobiology, Los Angeles, California 1986
27. Rettenmaier MA, Casanova DM, Panganiban RL, Berman ML, DiSaia PJ: Radical hysterectomy in the management of bulky stage 1B cervical cancer. The Society of Pelvic Surgeons 36th Annual Meeting, Newport Beach, California 1986
28. Syed NAM, DiSaia PJ, Berman ML, Rettenmaier MA, Colman M: The use of open implants in the management of pelvic cancers. The Society of Pelvic Surgeons 36th Annual Meeting, Newport Beach, California 1986
29. Homesley HD, Blessing JA, Rettenmaier MA, Majors FJ, Twiggs L: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. The Society of Gynecologic Oncologist Annual Meeting. Miami, Florida 1987
30. Douglas J, Flowers F, Rettenmaier MA, Britt P, Weck P: Comparison of interferon alfa-N1, podophyllin or combination therapy for recurrent genital warts. VIIth International Congress of Virology. Ottawa, Ontario, Canada 1987
31. Mannel RS, Berman ML, Rettenmaier MA, Walker J, Sheets EE, DiSaia PJ: Evaluation of clinical stage II endometrial cancer treated with primary surgical therapy. Western Association of Gynecologic Oncologists Annual Meeting. Tucson, Arizona 1987
32. Walker J, Wilczynski S, Bergen S, Sheets EE, Rettenmaier MA, Berman M, DiSaia PJ: Is cervical cancer in young women a different disease? Western Association of Gynecologic Oncologists Annual Meeting. Tucson, Arizona 1987
33. Puthawala AA, Syed AMN, DiSaia PJ, Berman M, Rettenmaier MA: Thermoendocurietherapy for recurrent and/or persistent pelvic tumors. Western Association of Gynecologic Oncologists Annual Meeting. Tucson, Arizona 1987
34. Douglas J, Eron L, Delgado G, Rettenmaier MA, Flowers F, Britt P, Weck P: A multicenter randomized trial of systemic interferon, podophyllin, or both for recurrent anogenital warts. Sixth Papilloma Virus Workshop
35. Stratton JA, Nguyen BL, Rettenmaier MA, Berman ML, DiSaia PJ: Concordance of CA125 and LSA tumor associated antigen levels and the disease status of patients with gynecological malignancies. American Society of Clinical Oncology 23rd Annual Meeting. Atlanta, Georgia 1987
36. Mannel RS, Stratton JA, Rettenmaier MA, Liao SY, DiSaia PJ: Cis-Dichlorodiammineplatinum(II) comparison of antitumor activity and toxicity as a function of saline concentration in the vehicle of administration. American Association for Cancer Research 78th Annual Meeting. Atlanta, Georgia 1987
37. Rettenmaier MA, et al: Phase I IP Cisplatin/Cytarabine. Second International Conference on Intracavitary Chemotherapy.
San Diego, California 1988
38. Rettenmaier MA, et al: Phase II Cytarabine/Bleomycin/Cisplatin as Salvage. Second International Conference on Intracavitary Chemotherapy. San Diego, California 1988
39. Sutton G, Blessing J, McGuire W, Photopulos G, Rettenmaier MA: Phase II trial of ifosfamide in patients with recurrent or advanced mixed mesodermal tumors of the uterus. American Society of Clinical Oncologists Annual Meeting. New Orleans, Louisiana 1988
,
40. Mannel RS, Stratton JA, Rettenmaier MA, Liao SY, DiSaia PJ: Use of a murine model for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer. Society of Gynecologic Oncologists Annual. Meeting Miami, Florida 1988
41. Kreter B, Ozasa D, Rettenmaier MA, Bergen S: Tissue levels of cefonocid obtained during radical hysterectomy. American College of Clinical Pharmacy Meeting. Philadelphia, Pennsylvania 1988
42. Blessing JA, Schlaerth JB, Rettenmaier MA, Major FJ: Dose intensity study of weekly intramuscular methotrexate (WIM) for nonmetastatic gestational trophoblastic disease (NGTD). American Society of Clinical Oncologists Annual Meeting. San Francisco, California 1989
43. Bloss JD, Berman ML, Mukhurjee J, Manetta A, Emma D, Rettenmaier MA, DiSaia PJ: Bulky stage 1B cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Society of Gynecologic Oncologists Annual Meeting. San Antonio, Texas 1992
44. Brown JV, Peters WA, Rettenmaier MA, Karlan BY, Dillman RA, Smith MR, Drescher CW, Micha JP: A phase 1 trial of three day topotecan Q 21 days for recurrent epithelial mullerian malignancies. Society of Gynecologic Oncologists Annual Meeting. San Diego, California. 2000
45. Brown JV, Peters WA, Rettenmaier MA, Drescher CW, Smith MR, Dillman RA, Micha JP: Three-consecutive-day Topotecan is an active regimen for recurrent epithelial ovarian cancer. Society of Gynecologic Oncologist Annual Meeting. Miami, Florida 2002
46. Micha JP, Goldstein BH, Rettenmaier MA, Bader K, Graham C, Lopez K, Nickle M, Genesen M, Brown JV III: Pilot Study of Outpatient Paclitaxel, Carboplatin and Bevacizumab for Advanced Stage Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer. 11th Annual International Gynecologic Cancer Society Meeting. Santa Monica, CA 2006.
47. Abaid LN, Micha JP, Rettenmaier MA, Brown JV III, Mendivil AA, Lopez KL, Goldstein BH: A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Society of Gynecologic Oncology 42nd Annual Meeting. Austin, TX 2012
48. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV III, Micha JP, Lopez KL, Goldstein BH: A Comparison of Open Surgery, Robotic-Assisted Surgery and Conventional Laparoscopic Surgery in the Treatment of Morbidly Obese Endometrial Cancer Patients. ESJO Annual Meeting. Liverpool, UK 2013
49. Rettenmaier MA, Mendivil AA, Abaid LN, Brown III JV, Micha JP, Wilcox AM, Goldstein BH: Consolidation Hyperthermic Intraperitoneal Chemotherapy and Maintenance Chemotherapy Following Laparoscopic Cytoreductive Surgery in the Treatment of Ovarian Carcinoma. International Gynecologic Cancer Society Annual Meeting. Santiago, CL 2015
50. Micha JP, Rettenmaier MA, Brown III JV, Mendivil AA, Abaid LN, Lopez KL, Goldstein BH: A phase IV randomized study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting and activities of daily living in patients treated for gynecologic cancer. European Society of Gynaecological Oncology Annual Meeting. Nice, FR 2015
Grants
American Cancer Society – Cancer Research Institute
Phototherapy of Intraepithelial Neoplasia 1982
Cancer Research Coordinating Committee
University of California, Irvine
Phototherapy of Malignant and Premalignant Gynecologic Lesions 1983
National Cancer Institute
Division of Cancer Research
Photoradiation Therapy of Induced Dysplasia in Mice #r01 ca 33753-01 1983-6
Resource Allocation Advisory Committee
University of California, Irvine
Continuous Pelvic Arterial Infusion with Mitomycin-C for Squamous
Carcinoma of the Cervix Recurrent to the Pelvis after Radiation Therapy 1984
Ayerst Laboratories
Subjective Evaluation of the Efficacy of Phasic Premarin compared with
Fixed Dose Premarin in the Treatment of Vasomotor Symptoms of the
Natural Menopause (high dose regimen) 1986
Burroughs-Wellcome Laboratories
Randomized Comparison of Subcutaneous Interferon and Topical
Podophyllin Therapy for Treatment of Genital Condyloma 1986
Ribi Biochemical
Treatment of Advanced Ovarian Carcinoma with Intraperitoneal Ovamid 1986
Oclassen Pharmaceuticals
Condylox Therapy of Patients with Condyloma Acuminata 1989
Amgen
Carboplatinum/Cytoxan/Neupogen First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma 1992
Bristol Myers
Three Hour Taxol/Carboplatinum First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma 1993
Amgen
One Hour Taxol/Carboplatinum First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma 1995
Smith Kline Beecham
Three Day Topotecan
Second Line Treatment of Patients with Recurrent Ovarian Adenocarcinoma 1997
Eli Lilly
Gemzar/Taxol/Carboplatinum
First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma 1997
Altarex
Treatment of Recurrent Ovarian Cancer with Ovarex 1999
Post-Graduate Courses Presented
Office Gynecology Update
Long Beach, California 1984
Techno-Gynecology
Irvine, California 1986
Office Gynecology Update
Long Beach, California 1987, 1988, 1989, 1990
Colposcopy for the Family Practitioner
Anaheim, California 1990
Advances in Health Care for Women Over 40
New Orleans, Louisianna 1995